Faggioli, L <br/><br/>
Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line.  [electronic resource] 

 -  European journal of biochemistry  Aug 1996 
 - 624-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2956 
<br/><br/><label>Standard No.: </label>10.1111/j.1432-1033.1996.0624u.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Base Sequence<br/>Breast Neoplasms--genetics<br/>CCAAT-Enhancer-Binding Protein-delta<br/>CCAAT-Enhancer-Binding Proteins<br/>Carcinoma--genetics<br/>Cycloheximide--pharmacology<br/>Cytokines--pharmacology<br/>DNA-Binding Proteins--metabolism<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Interleukin-6--genetics<br/>Molecular Sequence Data<br/>NF-kappa B--metabolism<br/>Nuclear Proteins--metabolism<br/>Promoter Regions, Genetic<br/>RNA, Messenger--biosynthesis<br/>RNA, Neoplasm--biosynthesis<br/>Transcription Factors--metabolism<br/>Transcription, Genetic<br/>Transcriptional Activation<br/>Tumor Cells, Cultured